'Despite development challenges,drug developers have reason to be optimistic'

摘要

Despite a growing list of development challenges-including rising R&D costs,increasing regulatory stringency and mounting public hostility over safety and end-user costs-drug developers have cause for optimism,according to the Tufts Center for the Study of Drug Development.Contributing to that optimism.Tufts CSDD said,is greater use of new technologies to reduce late-stage development failures and contain rising costs,increased reliance on global outsourcing to speed development and reduce costs,and more coordination between U.S.and European regulators.